Sort
326,823 grants matching “clinical trial”
Zimbabwe: Community Intervention to Reduce HIV/STD Risk
$1,973,332Battelle Centers/Pub Hlth Res &Evaluatn · U10 · FY2004 · MH
CD40L adjuvanted clade C DNA and MVA HIV vaccines
$1,973,313Rama Rao Amara · Emory University · U19 · FY2015 · AI
Instrumentation for microSPECT and microPET imaging
$1,973,242Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Pathophysiology and Treatment of Fanconi Anemia
$1,973,219Markus Grompe · Oregon Health & Science University · P01 · FY2020 · HL
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$1,972,938Barbara Driver · Westat, Inc. · N01 · FY2024 · HD
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,972,714Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2023 · AI
Gene Therapy for Leber Congenital Amaurosis
$1,972,424University Of Florida · U10 · FY2002 · EY
Human Islet-Infiltrating T Cell Biology: Reactivity, Structure, and Function
$1,972,347Sally Choate Kent · Univ Of Massachusetts Med Sch Worcester · UC4 · FY2017 · DK
Clinical validity and utility of genomic targeted chemoprevention of PCa
$1,972,330Jianfeng Xu · Wake Forest University Health Sciences · RC2 · FY2009 · CA
Immunotherapeutic Modulation of Peanut Allergy
$1,972,129Robert A Wood · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
IMAGING AUTOIMMUNE DISEASE
$1,971,965Diane J Mathis · Harvard Medical School · P01 · FY2011 · AI
A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases
$1,971,749Karl H Donn · Parion Sciences, Inc. · R44 · FY2025 · HL
Open Drug Discovery Center for Alzheimer's Disease
$1,971,420Allan I Levey · Emory University · U54 · FY2022 · AG
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE
$1,971,020University Of Colorado Denver · U01 · FY2000 · HL
SWITCH Trial: Early Feasibility Study of Stentrode BCI for Augmentative Communication
$1,970,860Douglas J Weber · Carnegie-Mellon University · UH3 · FY2023 · NS
Perimenopause in Brain Aging and Alzheimer's Disease
$1,970,713Roberta Diaz Brinton · University Of Southern California · P01 · FY2015 · AG
Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease
$1,970,540Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
Restoration of Grasp and Reach in Cervical Spinal Cord Injury
$1,970,521Kevin L Kilgore · Case Western Reserve University · UH3 · FY2024 · NS
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,970,503Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
NINDS CENTER FOR CLINICAL TRIAL RESOURCES
$1,970,467Kathryn Hefner · The Emmes Company, Llc · N01 · FY2024 · DA
Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness
$1,970,462Katherine E Watkins · Rand Corporation · UF1 · FY2020 · MH
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$1,970,379Judith S. Currier · University Of California Los Angeles · U01 · FY2009 · AI
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
$1,970,313Geoffrey I Shapiro · Dana-Farber Cancer Inst · UM1 · FY2024 · CA
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$1,970,265Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2022 · DA
Molecular Imaging and Its Response to Therapy
$1,970,254University Of Washington · P01 · FY2004 · CA